Dr. Reddy's Laboratories Limited Operating Income | RDY

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Dr. Reddy's Laboratories Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
71.8 B	67.7 B	57.1 B	29.5 B	24.3 B	16 B	20.9 B	11.9 B	13.5 B	29.6 B	-	-	-	-	-

All numbers in INR currency

Indicator range from annual reports

Maximum	Minimum	Average
71.8 B	11.9 B	34.2 B

Quarterly Operating Income Dr. Reddy's Laboratories Limited

2025-Q4	2025-Q1	2024-Q4	2024-Q1	2023-Q4	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	71.8 B	-	67.7 B	-	57.1 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in INR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
71.8 B	57.1 B	65.6 B

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Ionis Pharmaceuticals IONS	-214 M	$ 43.5	0.62 %	$ 6.96 B	USA
Agios Pharmaceuticals AGIO	-472 M	$ 31.25	0.88 %	$ 1.81 B	USA
Foghorn Therapeutics FHTX	-86.4 M	$ 2.0	0.74 %	$ 126 M	USA
Inhibikase Therapeutics IKT	-52 M	$ 2.0	0.5 %	$ 197 M	USA
Kamada Ltd. KMDA	26.2 M	$ 8.0	1.34 %	$ 461 M	Israel
Intellia Therapeutics NTLA	-441 M	$ 12.75	4.0 %	$ 1.38 B	USA
Ultragenyx Pharmaceutical RARE	-535 M	$ 14.5	3.19 %	$ 1.43 B	USA
Viridian Therapeutics VRDN	-363 M	$ 19.0	2.16 %	$ 1.93 B	USA
AbbVie ABBV	15.1 B	$ 265.76	1.12 %	$ 470 B	USA
AbCellera Biologics ABCL	-217 M	$ 13.78	0.29 %	$ 4.12 B	Canada
Abeona Therapeutics ABEO	-89.4 M	$ 5.11	1.59 %	$ 271 M	USA
Arbutus Biopharma Corporation ABUS	-38.2 M	$ 4.67	4.94 %	$ 895 M	Canada
ACADIA Pharmaceuticals ACAD	105 M	$ 20.11	0.8 %	$ 3.39 B	USA
AC Immune SA ACIU	-69.3 M	$ 2.71	0.55 %	$ 273 M	Schweiz
Aclaris Therapeutics ACRS	-76.4 M	$ 4.27	0.79 %	$ 523 M	USA
Adagene ADAG	-21.4 M	$ 2.8	0.28 %	$ 165 M	China
ADC Therapeutics SA ADCT	-121 M	$ 1.23	8.85 %	$ 156 M	Schweiz
Adial Pharmaceuticals ADIL	-7.8 M	$ 4.35	5.58 %	$ 2.91 M	USA
ADMA Biologics ADMA	191 M	$ 10.11	4.01 %	$ 2.41 B	USA
Adaptive Biotechnologies Corporation ADPT	-57.1 M	$ 29.84	5.26 %	$ 4.53 B	USA
Agenus AGEN	-20.2 M	$ 8.73	4.43 %	$ 260 M	USA
AIM ImmunoTech AIM	-11.7 M	$ 0.19	5.56 %	$ 308 K	USA
Akebia Therapeutics AKBA	23.5 M	$ 0.91	5.26 %	$ 234 M	USA
Akari Therapeutics, Plc AKTX	-17.3 M	$ 8.76	0.46 %	$ 590 B	Britain
Aldeyra Therapeutics ALDX	-35.3 M	$ 0.92	4.88 %	$ 55.3 M	USA
Alector ALEC	-156 M	$ 1.99	9.94 %	$ 205 M	USA
Aligos Therapeutics ALGS	-88 M	$ 5.4	0.36 %	$ 53.4 M	USA
Alkermes plc ALKS	254 M	$ 42.76	2.42 %	$ 7.04 B	Irlanda
Allogene Therapeutics ALLO	-209 M	$ 1.5	0.33 %	$ 331 M	USA
Alnylam Pharmaceuticals ALNY	502 M	$ 219.89	0.08 %	$ 28.8 B	USA
Altimmune ALT	-94.5 M	$ 2.67	0.36 %	$ 235 M	USA
ALX Oncology Holdings ALXO	-104 M	$ 1.21	1.23 %	$ 64.9 M	USA
Amgen AMGN	9.08 B	$ 402.98	0.08 %	$ 217 B	USA
Amphastar Pharmaceuticals AMPH	140 M	$ 25.37	0.39 %	$ 1.19 B	USA
Amarin Corporation plc AMRN	-50.2 M	$ 12.09	0.31 %	$ 5.02 B	Irlanda
Amneal Pharmaceuticals AMRX	394 M	$ 20.35	0.25 %	$ 6.38 B	USA
AnaptysBio ANAB	32.3 M	$ 49.2	1.38 %	$ 1.43 B	USA
Anika Therapeutics ANIK	-11.1 M	$ 19.73	3.3 %	$ 283 M	USA
ANI Pharmaceuticals ANIP	111 M	$ 72.58	0.55 %	$ 1.46 B	USA
Annexon ANNX	-216 M	$ 4.2	0.24 %	$ 651 M	USA
Annovis Bio ANVS	-29.7 M	$ 1.2	1.69 %	$ 24.7 M	USA
Aprea Therapeutics APRE	-13.2 M	$ 0.68	0.16 %	$ 4.45 M	USA
Aptevo Therapeutics APVO	-26.3 M	$ 1.8	2.27 %	$ 568 K	USA
Aquestive Therapeutics AQST	-71.1 M	$ 4.57	0.44 %	$ 489 M	USA
Arcturus Therapeutics Holdings ARCT	-76.3 M	$ 14.66	12.51 %	$ 401 M	Israel
Ardelyx ARDX	-41 M	$ 3.39	1.5 %	$ 817 M	USA
argenx SE ARGX	1.05 B	$ 912.87	1.28 %	$ 56 B	Niderland
Armata Pharmaceuticals ARMP	-36.6 M	$ 3.66	3.98 %	$ 133 M	USA
Arcutis Biotherapeutics ARQT	-12.2 M	$ 25.15	0.04 %	$ 3.2 B	USA